UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                   Form 10-QSB/A

--------------------------------------------------------------------------------

(Mark one)

[X]  Quarterly  Report under Section 13 or 15(d) of the Securities  Exchange Act
     of 1934

For the quarterly period ended September 30, 2004

[_]  Transition Report Under Section 13 or 15(d) of the Securities  Exchange Act
     of 1934

For the transition period from ______________ to _____________

--------------------------------------------------------------------------------

Commission File No.: 000-32379

                            American Ammunition, Inc.
                       ---------------------------------
               (Name of small business registrant in its charter)



         California                                      91-2021594
-------------------------------                        -------------------------
(State or other jurisdiction of                        (I.R.S. Employer
incorporation or organization)                               Identification No.)

3545 NW 71st Street
Miami, FL                                                      33147
----------------------------------------               -------------------------
(Address of principal executive offices)                     (Zip Code)


Registrant's telephone number: (305) 835-7400


Securities registered under Section 12(b) of the Exchange Act:

    Title of each class                                Name of each exchange
                                                       on which registered
         None
-----------------------------                     ------------------------------


Securities registered under Section 12(g) of the Exchange Act:

                         Common Stock, $0.001 par value
                            ------------------------
                                (Title of class)


--------------------------------------------------------------------------------


Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days.       YES [X]   NO[_]

State the number of shares outstanding of each of the issuer's classes of common
equity as of the latest practicable date:    November 18, 2004: 74,740,580


Transitional Small Business Disclosure Format (check one):   YES [_]   NO [X]








                            American Ammunition, Inc.

             Form 10-QSB/A for the Quarter ended September 30, 2004

                                Table of Contents


                                                                           Page
Part I - Financial Information

  Item 1   Financial Statements                                              3

  Item 2   Management's Discussion and Analysis or Plan of Operation        23

  Item 3   Controls and Procedures                                          27


Part II - Other Information

  Item 1   Legal Proceedings                                                28

  Item 2   Recent Sales of Unregistered Securities and Use of Proceeds      28

  Item 3   Defaults Upon Senior Securities                                  28

  Item 4   Submission of Matters to a Vote of Security Holders              28

  Item 5   Other Information                                                28

  Item 6   Exhibits                                                         29


Signatures                                                                  29






------------------------

NOTE TO READER:  This amended filing  corrects a clerical error contained in the
original  filing  related  to the  presentation  of current  liabilities  in the
accompanying  balance sheet as of September 30, 2004 and the presentation of the
change in current  liabilities in the  accompanying  statement of cash flows for
the nine months ended  September  30, 2004.  There are no other changes from the
originally filed document.




                                                                               2




                                     Part I

Item 1 - Financial Statements




                   American Ammunition, Inc. and Subsidiaries
                           Consolidated Balance Sheets
                           September 30, 2004 and 2003

                                   (Unaudited)

                                                                September 30,   September 30,
                                                                    2004             2003
                                                                ------------    ------------
                                                                                    
                                     ASSETS
Current Assets
   Cash on hand and in bank                                     $     658,641     $1,347,532
   Accounts receivable - trade, net allowance for
     doubtful accounts of $-0- and $-0-, respectively                 255,236        288,503
   Inventory                                                        1,025,824        651,097
   Prepaid expenses                                                    62,725         36,421
                                                                -------------   -------------

     Total Current Assets                                           2,002,426      2,323,553
                                                                -------------   -------------


Property and Equipment - at cost or contributed value
   Manufacturing equipment                                          7,623,415      6,895,850
   Office furniture and fixtures                                       82,719         62,893
   Leasehold improvements                                             187,397        190,028
                                                                -------------   -------------
                                                                    7,893,531      7,148,771
   Accumulated depreciation                                        (4,595,887)    (3,891,321)
                                                                -------------   -------------

     Net Property and Equipment                                     3,297,644      3,257,450
                                                                -------------   -------------


Other Assets
   Deposits and other                                                 415,000         77,860
                                                                -------------   -------------

TOTAL ASSETS                                                    $   5,715,070   $  5,658,863
                                                                =============   =============




                                  - Continued -



   The accompanying notes are an integral part of these financial statements.

The  financial  information  presented  herein has been  prepared by  management
without audit by independent certified public accountants.

                                                                               3







                   American Ammunition, Inc. and Subsidiaries
                     Consolidated Balance Sheets - Continued
                           September 30, 2004 and 2003

                                   (Unaudited)

                                                                September 30,   September 30,
                                                                    2004             2003
                                                                ------------    ------------
                                                                                    
                    LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
   Current maturities of leases payable                          $        525   $       9,507
   Customer deposits                                                  220,006           4,100
   Accounts payable - trade                                           665,077         471,085
   Working capital advance                                             74,000         400,000
   Other accrued liabilities                                           82,866          63,071
                                                                -------------   -------------

     Total Current Liabilities                                      1,042,474         947,763

Long-Term Liabilities                                                       -               -
   Capital leases payable                                                   -             828
                                                                -------------   -------------

     Total Liabilities                                              1,042,474         948,591
                                                                -------------   -------------

Commitments and Contingencies

Convertible Debenture                                                 266,365         431,365
                                                                -------------   -------------

Mandatory Convertible Preferred Stock
   net of Beneficial Conversion Discount Feature
     91,700 and 123,700 shares issued and outstanding                 518,500         602,610
                                                                -------------   -------------

Stockholders' Equity
   Preferred stock - $0.001 par value
     20,000,000 shares authorized.
     1,795,320 shares allocated to Series A                                 -               -
     1,000,000 shares allocated to Series B                                 -               -
   Common stock - $0.001 par value.
     300,000,000 shares authorized.
     73,686,672 and 62,718,137 shares issued and outstanding           73,687          62,718
   Additional paid-in capital                                      23,098,312      19,961,671
   Accumulated deficit                                            (19,009,268)    (16,348,092)
                                                                -------------   -------------
                                                                    4,162,731       3,676,297
   Stock subscription receivable                                     (275,000)              -
                                                                -------------   -------------

   Total Stockholders' Equity                                       3,887,731       3,676,297
                                                                -------------   -------------

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                      $   5,715,070   $   5,658,863
                                                                =============   =============





   The accompanying notes are an integral part of these financial statements.

The  financial  information  presented  herein has been  prepared by  management
without audit by independent certified public accountants.

                                                                               4







                   American Ammunition, Inc. and Subsidiaries
      Consolidated Statements of Operations and Comprehensive Income (Loss)
             Nine and Three months ended September 30, 2004 and 2003

                                   (Unaudited)

                                              Nine months       Nine months     Three months      Three months
                                                 ended             ended           ended             ended
                                             September 30,      September 30,   September 30,     September 30,
                                                 2004              2003              2004              2003
                                             ---------------  ----------------  ----------------  -------------
                                                                                                 

Revenues                                     $     1,712,280  $      1,215,717  $        861,988  $     317,729
                                             ---------------  ----------------  ----------------  -------------

Cost of Sales
   Materials, Direct Labor
      and other direct costs                       1,911,210         1,713,888           308,503        614,748
   Depreciation                                      523,815           494,633           176,304        165,464
                                             ---------------  ----------------  ----------------  -------------
      Total Cost of Sales                          2,435,025         2,208,521           484,807        780,212
                                             ---------------  ----------------  ----------------  -------------

Gross Profit                                        (722,745)         (992,804)          377,181       (462,483)
                                             ---------------  ----------------  ----------------  -------------

Operating Expenses
   Research and development expenses                   8,332             9,208             1,858          8,824
   Marketing and promotion expenses                  368,458            30,350           114,404         16,835
   Other operating expenses                          845,663           788,599           250,570        330,127
   Bad debt expense                                   27,819                 -                 -              -
   Interest expense                                   15,825            26,270                58          9,725
   Depreciation expense                                5,681             3,387             1,894          1,129
   Compensation expense related to
      common stock issuances at less
      than "fair value"                              356,000           736,102                 -        371,798
                                             ---------------  ----------------  ----------------  -------------
      Total Operating Expenses                     1,627,778         1,593,916           368,784        738,498
                                             ---------------  ----------------  ----------------  -------------

Loss from Operations                              (2,350,523)       (2,586,720)            8,397     (1,200,981)

Other Income (Expense)
   Interest and other income                           1,409             2,594             1,155              -
   Amortization of Beneficial
      Conversion Feature Discount
      on Preferred Stock                                   -           (77,787)                -        (46,839)
                                             ---------------  ----------------  ----------------  -------------
Loss before Income Taxes                          (2,349,114)       (2,661,913)            9,552     (1,247,820)
Provision for Income Taxes                                 -                 -                 -              -
                                             ---------------  ----------------  ----------------  -------------

Net Loss                                          (2,349,114)       (2,661,913)            9,552     (1,247,820)
Other Comprehensive Income                                 -                 -                 -              -
                                             ---------------  ----------------  ----------------  -------------

Comprehensive Loss                           $    (2,349,114) $     (2,661,913) $          9,552  $  (1,248,820)
                                             ===============  ================  ================  =============

Loss per weighted-average share of
   common stock outstanding, computed
   on net loss - basic and fully diluted     $         (0.03) $          (0.04) $          (0.00) $       (0.02)
                                             ===============  ================  ================  =============
Weighted-average number of
   common shares outstanding                      70,873,791        59,222,995        73,673,416     61,683,424
                                             ===============  ================  ================  =============


   The accompanying notes are an integral part of these financial statements.

The  financial  information  presented  herein has been  prepared by  management
without audit by independent certified public accountants.

                                                                               5





                   American Ammunition, Inc. and Subsidiaries
                      Consolidated Statements of Cash Flows
                  Nine months ended September 30, 2004 and 2003

                                   (Unaudited)

                                                                  Nine months   Nine months
                                                                     ended          ended
                                                                 September 30,  September 30,
                                                                     2004           2003
                                                                 -------------- -------------
                                                                                     
Cash flows from operating activities
   Net loss for the year                                         $   (2,349,114)$  (2,661,913)
   Adjustments to reconcile net loss to
     net cash provided by operating activities
       Depreciation and amortization                                    529,496       498,020
       Bad debt expense                                                  27,819             -
       Accretion of Beneficial Conversion Feature
         Discount on Preferred Stock                                          -        77,787
       Compensation expense related to common stock
         issuances at less than "fair value"                            356,000       736,102
       Common stock issued for fees and services                         90,160             -
       (Increase) Decrease in
         Accounts receivable                                            237,780      (257,215)
         Inventory                                                       86,932      (266,283)
         Prepaid expenses, deposits and other                           (28,137)      (17,030)
       Increase (Decrease) in
         Accounts payable - trade                                        36,213        56,175
         Other accrued expenses                                          69,445        10,101
         Customer deposits                                              215,906       (76,853)
                                                                 -------------- -------------
Net cash used in operating activities                                  (727,500)   (1,901,109)
                                                                 -------------- -------------

Cash flows from investing activities
   Purchase of property and equipment                                  (436,214)      (58,845)
                                                                 -------------- -------------
Net cash used in investing activities                                  (436,214)      (58,845)
                                                                 -------------- -------------

Cash flows from financing activities
   Funding of working capital advance                                    74,000       400,000
   Principal paid on long-term debt                                           -      (450,000)
   Principal paid on long-term capital leases                            (7,316)       (7,013)
   Cash paid to obtain capital                                                -       (61,850)
   Cash received on convertible debenture                                     -       350,000
   Cash received on sale of convertible preferred stock                       -       458,500
   Cash received on sale of common stock                              1,250,000     2,460,533
                                                                 -------------- -------------
Net cash provided by financing activities                             1,316,684     3,150,170
                                                                 -------------- -------------

Increase (Decrease) in Cash                                             152,970     1,190,216

Cash at beginning of year                                               505,671       157,316
                                                                 -------------- -------------

Cash at end of year                                              $      658,641 $   1,347,532
                                                                 ============== =============


                                  - Continued -

   The accompanying notes are an integral part of these financial statements.

The  financial  information  presented  herein has been  prepared by  management
without audit by independent certified public accountants.

                                                                               6







                   American Ammunition, Inc. and Subsidiaries
                      Consolidated Statements of Cash Flows
                  Nine months ended September 30, 2004 and 2003

                                   (Unaudited)

                                                                  Nine months   Nine months
                                                                     ended          ended
                                                                 September 30,  September 30,
                                                                     2004           2003
                                                                 -------------- -------------
                                                                                     
Supplemental disclosure of interest
   and income taxes paid
     Interest paid for the period                                $          825 $      26,170
                                                                 ============== =============
     Income taxes paid for the period                            $            - $           -
                                                                 ============== =============


Supplemental disclosure of non-cash
   investing and financing activities
     Asset purchase agreement for equipment,
     inventory and intellectual property accrued
     as a component of accounts payable                          $      500,000 $           -
                                                                 ============== =============






   The accompanying notes are an integral part of these financial statements.

The  financial  information  presented  herein has been  prepared by  management
without audit by independent certified public accountants.

                                                                               7





                   American Ammunition, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements


Note A - Organization and Description of Business

American Ammunition,  Inc. (AAI or Company) was incorporated on February 1, 2000
in the State of California as  FirsTelevision.com.  AAI subsequently changed its
corporate name to FBI Fresh Burgers International which unsuccessfully  marketed
a business plan concept of a national "fast food" restaurant chain.

On September 29, 2001, the Company, F&F Equipment, Inc. (F&F) and the individual
shareholders of F&F entered into an "Agreement For The Exchange Of Common Stock"
(Exchange  Agreement)  whereby the  shareholders of F&F exchanged  100.0% of the
issued and outstanding stock of F&F for 21,000,000  post-forward split shares of
restricted,  unregistered common stock of the Company. F&F Equipment,  Inc. then
became a wholly-owned subsidiary of the Company.

F&F Equipment,  Inc.(Company) was incorporated on October 4, 1983 under the laws
of the State of Florida.  The Company  was formed to engage  principally  in the
"import,  export,  retail & wholesale of firearms equipment,  ammunition & other
devices and for the purpose of transacting any and/or all lawful  business." The
Company  conducts  its business  operations  under the assumed name of "American
Ammunition".

In June  2002,  American  Ammunition,  Inc.  formed a wholly  owned  subsidiary,
Industrial  Plating  Enterprise Co. (IPE),  which started production on June 14,
2002.  IPE is a fully  licensed  and approved  state of the art  electrochemical
metallization  facility for processing the Company's line of projectiles as well
as other  products  and services  while  employing  environmentally  sound water
conservation  and proven  waste  treatment  techniques.  The  facility  meets or
exceeds all current  environmental  requirements  and enjoys the  "conditionally
exempt small quantity generator" status for State and Federal regulations.


Note B - Preparation of Financial Statements

The  acquisition of F&F  Equipment,  Inc., on September 29, 2001, by the Company
effected a change in control and was  accounted  for as a "reverse  acquisition"
whereby F&F Equipment,  Inc. was the accounting acquiror for financial statement
purposes.  Accordingly,  the historical  financial statements of the Company are
those of F&F Equipment,  Inc. from it's inception and those of the  consolidated
entity subsequent to the September 29, 2001 transaction date.

The  Company and its  subsidiaries  follow the accrual  basis of  accounting  in
accordance with accounting principles generally accepted in the United States of
America and have adopted a year-end of December 31 for all entities.



                                                                               8





                   American Ammunition, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements


Note B - Preparation of Financial Statements - Continued


The preparation of financial statements in conformity with accounting principles
generally  accepted in the United States of America requires  management to make
estimates  and  assumptions  that  affect  the  reported  amounts  of assets and
liabilities  and disclosure of contingent  assets and liabilities at the date of
the  financial  statements  and the  reported  amounts of revenues  and expenses
during the reporting period. Actual results could differ from those estimates.

Management further acknowledges that it is solely responsible for adopting sound
accounting  practices,   establishing  and  maintaining  a  system  of  internal
accounting  control and preventing and detecting  fraud. The Company's system of
internal  accounting  control is designed to assure,  among other items, that 1)
recorded  transactions  are valid; 2) valid  transactions  are recorded;  and 3)
transactions  are  recorded in the proper  period in a timely  manner to produce
financial  statements which present fairly the financial  condition,  results of
operations  and cash  flows of the  Company  for the  respective  periods  being
presented

For  segment  reporting  purposes,  the Company  operated  in only one  industry
segment during the periods represented in the accompanying  financial statements
and makes all  operating  decisions and  allocates  resources  based on the best
benefit to the Company as a whole.

During interim periods, the Company follows the accounting policies set forth in
its annual  audited  financial  statements  filed with the U. S.  Securities and
Exchange  Commission  on its  Annual  Report on Form  10-KSB  for the year ended
December 31, 2003.  The  information  presented  within these interim  financial
statements  may not include all  disclosures  required by accounting  principles
generally  accepted in the United  States of America and the users of  financial
information  provided for interim  periods should refer to the annual  financial
information and footnotes when reviewing the interim financial results presented
herein.

In the opinion of management,  the accompanying  interim  financial  statements,
prepared in  accordance  with the U. S.  Securities  and  Exchange  Commission's
instructions   for  Form  10-QSB,   are   unaudited  and  contain  all  material
adjustments,  consisting  only of  normal  recurring  adjustments  necessary  to
present fairly the financial condition,  results of operations and cash flows of
the Company for the respective  interim  periods  presented.  The current period
results of operations are not necessarily indicative of results which ultimately
will be reported for the full fiscal year ending December 31, 2004.

The  accompanying  consolidated  financial  statements  contain the  accounts of
American Ammunition, Inc. and its wholly-owned subsidiaries, F&F Equipment, Inc.
and Industrial Plating Enterprise Co. All significant intercompany  transactions
have been eliminated.  The consolidated entities are collectively referred to as
"Company".


Note C - Summary of Significant Accounting Policies

1.   Cash and cash equivalents

     For  Statement of Cash Flows  purposes,  the Company  considers all cash on
     hand  and  in  banks,  certificates  of  deposit  and  other  highly-liquid
     investments with maturities of three months or less, when purchased,  to be
     cash and cash equivalents.

     Cash  overdraft  positions may occur from time to time due to the timing of
     making bank deposits and releasing checks, in accordance with the Company's
     cash management policies.

2.   Accounts receivable and Revenue Recognition

     In the normal course of business,  the Company extends  unsecured credit to
     virtually  all of its  customers  which are located  throughout  the United
     States.  Because of the credit risk  involved,  management  has provided an
     allowance for doubtful accounts which reflects its opinion of amounts which
     will   eventually   become   uncollectible.   In  the  event  of   complete
     non-performance, the maximum exposure to the Company is the recorded amount
     of trade  accounts  receivable  shown on the  balance  sheet at the date of
     non-performance.

     The Company ships all product on an FOB-Plant basis.  Accordingly,  revenue
     is recognized by the Company at the point at which an order is shipped at a
     fixed price, collection is reasonably assured, the Company has no remaining
     performance obligations and no right of return by the purchaser exists.


                                                                               9





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note C - Summary of Significant Accounting Policies - Continued

3.   Inventory

     Inventory  consists of raw  materials,  work-in-process  and finished goods
     related to the production and sale of small arms  ammunition.  Inventory is
     valued at the lower of cost or market using the first-in, first-out method.

4.   Property, plant and equipment

     Property and  equipment are recorded at  historical  cost.  These costs are
     depreciated over the estimated useful lives of the individual  assets using
     the straight-line method, generally three to ten years.

     Gains and losses from  disposition of property and equipment are recognized
     as incurred and are included in operations.

5.   Income Taxes

     The Company uses the asset and liability  method of  accounting  for income
     taxes.  At September 30, 2004 and 2003, the deferred tax asset and deferred
     tax  liability  accounts,  as  recorded  when  material  to  the  financial
     statements,  are entirely the result of  temporary  differences.  Temporary
     differences   represent  differences  in  the  recognition  of  assets  and
     liabilities for tax and financial reporting purposes, primarily accumulated
     depreciation and amortization, allowance for doubtful accounts and vacation
     accruals.

     As of September  30, 2004 and 2003,  the deferred tax asset  related to the
     Company's net  operating  loss  carryforward  is fully  reserved.  If these
     carryforwards are not utilized, they will begin to expire in 2005.

6.   Earnings (loss) per share

     Basic  earnings  (loss) per share is computed  by  dividing  the net income
     (loss) available to common shareholders by the  weighted-average  number of
     common shares  outstanding  during the respective  period  presented in our
     accompanying financial statements.  Fully diluted earnings (loss) per share
     is  computed  similar  to basic  income  (loss) per share  except  that the
     denominator is increased to include the number of common stock  equivalents
     (primarily  outstanding  options and  warrants).  Common stock  equivalents
     represent the dilutive  effect of the assumed  exercise of the  outstanding
     stock options and warrants,  using the treasury stock method, at either the
     beginning  of the  respective  period  presented  or the date of  issuance,
     whichever is later, and only if the common stock equivalents are considered
     dilutive  based  upon the  Company's  net  income  (loss)  position  at the
     calculation date.

     At September 30, 2004 and 2003, the Company had no common stock equivalents
outstanding.

7.   Advertising costs

     The Company does not conduct any direct  response  advertising  activities.
     For non-direct response advertising, the Company charges the costs of these
     efforts  to  operations  at the  first  time  the  related  advertising  is
     published.



                                                                              10





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note D - Fair Value of Financial Instruments

The carrying amount of cash,  accounts  receivable,  accounts  payable and notes
payable, as applicable,  approximates fair value due to the short term nature of
these items  and/or the current  interest  rates  payable in relation to current
market conditions.

Interest  rate risk is the risk  that the  Company's  earnings  are  subject  to
fluctuations  in interest  rates on either  investments  or on debt and is fully
dependent  upon  the  volatility  of  these  rates.  The  Company  does  not use
derivative instruments to moderate its exposure to interest rate risk, if any.

Financial  risk  is  the  risk  that  the  Company's  earnings  are  subject  to
fluctuations in interest rates or foreign exchange rates and are fully dependent
upon the  volatility  of  these  rates.  The  company  does  not use  derivative
instruments to moderate its exposure to financial risk, if any.


Note E - Concentrations of Credit Risk

The Company  maintains its cash accounts in a financial  institution  subject to
insurance coverage issued by the Federal Deposit Insurance  Corporation  (FDIC).
Under FDIC rules, the separate companies are each entitled to aggregate coverage
of  $100,000  per  account  type  per  separate   legal  entity  per   financial
institution.  During the years ended December 31, 2003 and 2002 and for the nine
month  period ended  September  30, 2004,  respectively,  the various  operating
companies had deposits in a financial  institution with credit risk exposures in
excess of  statutory  FDIC  coverage.  The Company  has  incurred no losses as a
result of any of these unsecured situations.


Note F - Inventory

As of  September  30,  2004  and  2003,  inventory  consisted  of the  following
components:

                               September 30,    September 30,
                                  2004               2003
                               -------------    -------------

         Raw materials           $   231,456      $   205,818
         Work in process             515,622          246,477
         Finished goods              278,746          198,802
                                 -----------      -----------

         Totals                  $ 1,025,824      $   651,097
                                 ===========      ===========




                (Remainder of this page left blank intentionally)



                                                                              11





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note G - Property and Equipment

Property and equipment consist of the following components:

                                    September 30,    September 30,    Estimated
                                        2004             2003        useful life
                                    -------------- ---------------   -----------

   Manufacturing equipment          $   7,623,415     $  6,895,850    3-10 years
   Office furniture and fixtures           82,719           62,893     3-7 years
   Leasehold improvements                 187,397          190,028    8-20 years
                                    -------------     ------------
                                        7,893,531        7,148,771
   Accumulated depreciation            (4,595,887)      (3,891,321)
                                    -------------     ------------

   Net property and equipment       $   3,297,644     $  3,257,450
                                    =============     ============

Total  depreciation  expense charged to operations for the respective nine month
periods  ended  September  30,  2004  and 2003 was  approximately  $529,496  and
$498,020.

Included in the amounts  reflected  in the  accompanying  balance  sheet are the
following fixed assets on long-term capital leases:

                                            September 30,    September 30,
                                                2004               2003
                                            -------------    -------------

     Manufacturing equipment                 $   153,400      $   153,400
     Less accumulated depreciation               (81,364)         (66,024)
                                             -----------      -----------
                                             $    72,036      $    87,376
                                             ===========      ===========


Note H - Working Capital Advance

On March 13, 2003, La Jolla Cove  Investors,  Inc.,  the holder of the Company's
convertible  debenture,  advanced the Company an additional $200,000 for working
capital  purposes.  At La Jolla Cove's sole  discretion,  the $200,000  could be
allocated in any  proportion  to a) an increase in the  principal  amount of the
debenture and/or b) a prepayment for a future warrant  exercise.  During the 2nd
quarter of 2003, La Jolla  elected to add this balance to the principal  balance
on the convertible debenture.

In August 2004,  the  Company's  controlling  shareholders  advanced the Company
approximately  $74,000 for working  capital to fund  certain  capital  equipment
purchases.  These  advances  are  non-interest  bearing and are  repayable  upon
demand.




                (Remainder of this page left blank intentionally)



                                                                              12





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note I- Capital Leases Payable

Capital leases payable consist of the following as of September 30, 2004 and
2003, respectively:



                                                                  September 30, September 30,
                                                                    2004            2003
                                                                  ------------- -------------
                                                                                    
Three  capital  leases,  respectively,  payable  to  various
equipment  financing  companies.  Interest  ranging  between
11.37% and 14.05%. Payable in aggregate monthly installments
of approximately  $935,  including accrued  interest.  Final
maturities  occur between  September 2004 and December 2004.
Collateralized  by  the  underlying   leased   manufacturing
equipment.                                                         $     525    $  10,335

     Less current maturities                                            (525)      (9,507)
                                                                   ---------    ---------
     Long-term portion                                             $       -    $     828
                                                                   =========    =========


Future maturities of capital leases payable are as follows:

                   Year ending
                   December 31      Amount
                   ------------------------

                    2004            $ 2,606
                                    =======

Note J - Convertible Debenture

On October 4, 2002, the Company issued an 8.0% Convertible Debenture (Debenture)
in the face  amount of  $250,000  and a Warrant  which  requires  the  Holder to
purchase  shares of common stock equal to ten (10) times the number of shares of
common stock issued to the Holder on  conversion of the  Debenture.  In no event
shall the number of shares issued under the Warrant exceed 30,000,000.

During the second  quarter of Calendar  2003,  the Holder made  additional  cash
advances  to the  Company  totaling  $350,000  which  were  applied  to the then
outstanding principal balance on the Debenture.

The Debenture  bears  interest at 8.0% and matures on October 4, 2004.  The full
principal  amount  of the  Debenture  is due upon  default,  as  defined  in the
Debenture  agreement.  The  Debenture  interest  is  payable  monthly in arrears
commencing on November 15, 2002.



                                                                              13





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note J - Convertible Debenture - Continued

At June  30,  2004  and  2003,  respectively,  the  outstanding  balance  on the
Debenture was approximately $266,365 and $524,865.

In  December   2002,   the  Company  and  the  Debenture   Holder   amended  the
above-referenced debenture and warrants as follows:

     The number of common  shares into which the  debenture  may be converted is
     equal to the dollar amount of the debenture being  converted  multiplied by
     eleven, minus the product of the conversion price,  multiplied by ten times
     the  dollar  amount  of  the  debenture  being  converted,  divided  by the
     conversion  price.  The  conversion  price is obtained by  multiplying  the
     average of the five (5) lowest Volume Weighted Average Prices (VWAP) during
     the 20  trading  days  prior  to the  date of  conversion  by the  Discount
     Multiplier of 80%.

     The warrants are exercisable at $1.00 per share for up to 2,500,000 shares.
     The warrant holder is obligated to exercise the warrant  concurrently  with
     the  conversion  of the debenture for a number of shares equal to ten times
     the dollar amount of the debenture being converted.

The Company was obligated to file a Registration Statement under the Securities
Act of 1933 to register the underlying conversion shares on either Form SB-2 or
S-3. This Registration Statement was declared effective by the U. S. Securities
and Exchange Commission on May 14, 2003.

The Debenture Holder has  contractually  committed to convert not less than 5.0%
and not more than  10.0% of the  original  face value of the  Debenture  monthly
beginning the month after the effective date of the  Registration  Statement and
the Holder is required to concurrently  exercise warrants and purchase shares of
common stock equal to ten (10) times the number of shares of common stock issued
to the Holder upon the respective mandatory conversion of the Debenture.

The Holder has further  contractually  agreed to restrict its ability to convert
the  Debenture or exercise  their  warrants and receive  shares of the Company's
common  stock  such  that  the  number  of  shares  held by the  Holder  and its
affiliates  after such  conversion or exercise does not exceed 4.99% of the then
issued and outstanding shares of common stock of the Company.

In the event an  election  to convert is made and the  volume  weighted  average
price of the Company's  common stock is below $0.30 per share, the Company shall
have the right to prepay  any  portion  of the  outstanding  Debenture  that was
elected to be converted, plus any accrued and unpaid interest, at 125.0%.






                                                                              13





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note J - Convertible Debenture - Continued



Due to the  contractually  agreed  mandatory  conversion of this Debenture,  the
Company has  reflected  this  transaction  in its balance sheet as a "mezzanine"
level debt  obligation on its balance  sheet,  between "Total  Liabilities"  and
"Stockholders'  Equity". Upon the respective mandatory  conversion,  the Company
will  relieve  the  respective  portion  of the  Debenture  and the any  related
accrued,  but unpaid interest,  and credit this amount to the respective "common
stock" and "additional  paid-in capital"  accounts in the  stockholder's  equity
section for the par value and excess amount over the par value of the respective
shares issued.

As the warrant is  non-detachable  from the Debenture and requires  simultaneous
exercise upon  conversion of the Debenture,  no value was assigned to the issued
warrant.  Upon exercise of the warrant,  the Company will record the issuance of
the  underlying  shares as a new  issuance  of common  stock on the date of each
respective exercise.

On various dates through June 30, 2004, the Debenture  Holder elected to convert
an  aggregate  $333,635,  through  29  separate  transactions,   in  outstanding
Debenture  principal into restricted,  unregistered  common stock. This election
caused the Company to issue 8,711,753 shares of restricted,  unregistered common
stock to the Debenture Holder. Additionally, pursuant to the contract terms, the
Debenture Holder concurrently  exercised a portion of the outstanding Warrant to
purchase 3,336,350 shares of the Company's restricted, unregistered common stock
for gross proceeds of $3,336,350.

As of June 30, 2004,  pursuant to the  conversion  terms of the  Debenture,  the
Debenture Holder is in arrears in the contractually  obligated conversions,  and
accordingly,  the related  mandatory  warrant  exercise  and owes the Company an
aggregate  $275,000  in cash  for  Warrant  exercise  and  debenture  conversion
transactions.




                (Remainder of this page left blank intentionally)




                                                                              14





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note K - Preferred Stock Transactions

Preferred stock consists of the following as of September 30, 2004 and 2003,
respectively:



                                              September 30, 2004      September 30, 2003
                                              ------------------      ------------------
                                              # shares   value       # shares    value
                                              -------- ---------     --------  ---------
                                                                         
Series A Cumulative Convertible Stock           12,000 $  60,000       32,000  $ 160,000
Series B Cumulative Convertible Stock           91,700   458,500       91,700    458,500
                                              -------- ---------     --------  ---------
                                               103,700   518,500      123,700    618,500
                                                       =========               =========
Beneficial Conversion Feature Discount                                           (15,890)
                                                       ---------               ---------

     Totals                                              518,500               $ 602,610
                                                       =========               =========


In September,  October and November 2001, the Company sold an aggregate  222,600
shares of $5.00 Series A Convertible  Preferred Stock (Series A Preferred Stock)
for total  proceeds  of  approximately  $1,113,000  through a Private  Placement
Memorandum.  The Series A Convertible  Preferred  Stock  provides for cumulative
dividends at a rate of 8.0% per year,  payable  quarterly,  in cash or shares of
the  Company's  common stock at the Company's  election.  Each share of Series A
Preferred  Stock is  convertible  into 11 shares of the  Company's  common stock
initially  at any time  after 6 months  of the  date of issue  and  prior to the
notice of redemption  at the option of the holder,  subject to  adjustments  for
customary  anti-dilution events. In December 2001, at the request of the holders
of the Series A Preferred Stock, the Company and the individual holders modified
the holding period for conversion to allow for conversion in December 2001.

In September 2001, the Company's principal stockholder  converted  approximately
$4,007,327 of unsecured  debt and  approximately  $3,546,273  of cumulative  and
unpaid accrued interest into 1,510,710 shares of Series A Preferred Stock.

In  September  2001, a creditor of the Company  agreed to convert  approximately
$10,000 of trade accounts payable into 2,000 shares of Series A Preferred Stock.

In December 2001,  concurrent with a modification in the holding period prior to
conversion,  certain holders of the Series A Preferred Stock orally notified the
Company of their intent to exercise the conversion  features on 1,749,720 issued
and outstanding  shares of Series A Preferred  Stock into  19,246,920  shares of
common  stock prior to December  31,  2001.  Due to the timing of the  requisite
documentation,  the  clerical  activities  related to this  conversion  were not
completed until February 2002.

In conjunction with the Series A Preferred Stock, certain shares were sold after
the Company's common stock was approved for trading by the National  Association
of Securities  Dealers on the OTC Bulletin  Board in October 2001. The shares of
Series A Preferred  Stock sold  subsequent  to this date had an  equivalent  per
share  value of  common  stock  below  the  ending  quoted  market  price of the
Company's common stock on their respective issue dates. This difference  created
a Beneficial  Conversion  Feature  Discount of  approximately  $1,207,993.  This
discount was then  amortized  over the unexpired time period between the date of
issue of the eligible shares and the eligible  conversion date, as amended.  All
of the shares sold  subsequent  to the initial  trading  date were  converted in
December  2001  and,  accordingly,  the  approximate  $1,207,993  in  Beneficial
Conversion Feature Discount was fully amortized to operations.

In December 2002, a holder of 5,000 shares of Series A Preferred Stock exercised
his  conversion  rights and converted  these shares of Series A Preferred  Stock
into 55,000 shares of restricted, unregistered common stock.


                                                                              15





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note K - Preferred Stock Transactions - Continued

In January 2003,  three  separate  holders of 9,000 shares of Series A Preferred
Stock exercised their  conversion  rights and converted these shares of Series A
Preferred stock into 99,000 shares of restricted, unregistered common stock.

In May 2003,  the Company  sold an  aggregate  91,700  shares of $5.00  Series B
Convertible  Preferred  Stock (Series B Preferred  Stock) for total  proceeds of
approximately  $458,500 through a separate  Private  Placement  Memorandum.  The
Series B Convertible Preferred Stock provides for cumulative dividends at a rate
of 8.0% per year, payable  quarterly,  in cash or shares of the Company's common
stock at the  Company's  election.  Each  share of Series B  Preferred  Stock is
convertible  into 11 shares of the Company's  common stock initially at any time
after 6 months of the date of issue and prior to the notice of redemption at the
option of the holder, subject to adjustments for customary anti-dilution events.


Note L - Common Stock Transactions

In January 2003, the Company  issued an aggregate  937,568 shares of restricted,
unregistered  common stock for cash proceeds of  approximately  $324,182.  These
sales  were made at a price of either  $0.23 or $0.36  per  share,  which was in
excess of the discounted "fair value" of the Company's common stock based on the
quoted closing price of the Company's common stock on the date of the respective
transaction.  The proceeds of this transaction  were used for operating  working
capital.  The Company relied upon Section 4(2) of the Securities Act of 1933, as
amended,  for an exemption from  registration of these shares and no underwriter
was used in this transaction.

In February 2003, the Company issued 384,615 shares of restricted,  unregistered
common stock for cash proceeds of approximately $100,000.  These sales were made
at a price of $0.26 per  share,  which was in  excess  of the  discounted  "fair
value" of the  Company's  common stock based on the quoted  closing price of the
Company's common stock on the date of the respective  transaction.  The proceeds
of this  transaction  were used to reduce the  Company's  outstanding  long-term
debt.  The Company  relied upon Section 4(2) of the  Securities  Act of 1933, as
amended,  for an exemption from  registration of these shares and no underwriter
was used in this transaction.

In March 2003, the Company  issued  972,222  shares of restricted,  unregistered
common stock for cash proceeds of approximately $350,000.  These sales were made
at a price of $0.36 per  share,  which was in  excess  of the  discounted  "fair
value" of the  Company's  common stock based on the quoted  closing price of the
Company's common stock on the date of the respective  transaction.  The proceeds
of this  transaction  were used to reduce the  Company's  outstanding  long-term
debt.  The Company  relied upon Section 4(2) of the  Securities  Act of 1933, as
amended,  for an exemption from  registration of these shares and no underwriter
was used in this transaction.

In March 2003,  the Company  issued an aggregate  966,608  shares of restricted,
unregistered  common  stock to the  Holder  of the  Company's  8.0%  Convertible
Debenture  upon notice of  conversion  of $35,000 of  outstanding  principal and
exercise of a portion of the outstanding  warrant to purchase  350,000 shares of
common stock.  This transaction was valued at $385,000,  or approximately  $0.40
per share,  which was in excess of the discounted  "fair value" of the Company's
common stock based on the quoted closing price of the Company's  common stock on
the date of the respective  transaction.  The cash proceeds of this  transaction
were used to provide working capital and support operations.


                                                                              16





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note L - Common Stock Transactions - Continued

In May 2003, the Company issued 1,967 shares of restricted,  unregistered common
stock in payment of  approximately  $1,200 in accrued  dividends  payable on the
Company's  outstanding  Series A Preferred Stock for the quarter ended March 31,
2003.  The Company  relied upon Section 4(2) of the  Securities  Act of 1933, as
amended,  for an exemption from  registration of these shares and no underwriter
was used in this transaction.

During the period from July 1, 2003  through  September  30,  2003,  the Company
issued  an  aggregate   2,902,129   shares  of  common  stock,  in  15  separate
transactions,  in  exchange  for the  redemption  of  approximately  $93,500  in
outstanding  debenture  balance  and  approximately  $935,000  in cash  from the
exercise of the  affiliated  warrant.  Where the closing  price of the Company's
common stock was in excess of the  respective  price per share on the respective
transaction   date,   the  Company   recognized  a  charge  to  operations   for
"compensation  expense  related  to common  stock  issuances  at less than "fair
value".  The cumulative effect of transactions  where the transaction  price, as
established in the Debenture  Agreement,  was less than the closing price on the
date  of  the  respective  transactions  resulted  in  a  cumulative  charge  to
operations of approximately $317,539 during this time period.

In October 2003, in a separate transaction, the Company sold 2,200,000 shares of
restricted,  unregistered common stock to the Debenture Holder for cash proceeds
of approximately $400,000, or approximately $0.18 per share, which was in excess
of the discounted "fair value" of the Company's common stock based on the quoted
closing  price of the  Company's  common  stock  on the  date of the  respective
transaction.  The cash proceeds of this transaction were used to provide working
capital and support operations.

In October  2003,  the Company  issued an aggregate  1,659,847  shares of common
stock,  in  3  separate   transactions,   in  exchange  for  the  redemption  of
approximately   $40,000  in  outstanding  debenture  balance  and  approximately
$400,000 in cash from the exercise of the affiliated warrant.  Where the closing
price of the Company's  common stock was in excess of the  respective  price per
share on the respective  transaction  date,  the Company  recognized a charge to
operations for  "compensation  expense related to common stock issuances at less
than "fair value".  The cumulative effect of transactions  where the transaction
price,  as  established  in the Debenture  Agreement,  was less than the closing
price on the date of the respective transactions resulted in a cumulative charge
to operations of approximately $146,189 during this time period.

In October 2003,  the Company  issued an aggregate  37,866 shares of restricted,
unregistered  common  stock in  payment  of  approximately  $16,710  in  accrued
dividends payable on the Company's  outstanding  Series A and Series B Preferred
Stock for the quarters ended June 30, 2003 and September 30, 2003, collectively.
The Company  relied upon Section 4(2) of the Securities Act of 1933, as amended,
for an exemption from  registration  of these shares and no underwriter was used
in this transaction.





                (Remainder of this page left blank intentionally)








                                                                              17





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note L - Common Stock Transactions - Continued

In January 2004, the Company  issued 38,038 shares of  restricted,  unregistered
common stock in payment of approximately $10,000 in accrued dividends payable on
the Company's  outstanding Series A and Series B Preferred Stock for the quarter
ended  December 31, 2003. The Company relied upon Section 4(2) of the Securities
Act of 1933, as amended,  for an exemption from registration of these shares and
no underwriter was used in this transaction.

During the period  from  January 1, 2004  through  March 31,  2004,  the Company
issued  an  aggregate  2,400,000  shares of common  stock,  in two (2)  separate
transactions,  in  exchange  for the  redemption  of  approximately  $50,000  in
outstanding  debenture  balance  and  approximately  $500,000  in cash  from the
exercise of the  affiliated  warrant.  Where the closing  price of the Company's
common stock was in excess of the  respective  price per share on the respective
transaction   date,   the  Company   recognized  a  charge  to  operations   for
"compensation  expense  related  to common  stock  issuances  at less than "fair
value".  The cumulative effect of transactions  where the transaction  price, as
established in the Debenture  Agreement,  was less than the closing price on the
date  of  the  respective  transactions  resulted  in  a  cumulative  charge  to
operations of approximately $321,000 during this time period.

In May 2004, the Company issued 25,260 shares of restricted, unregistered common
stock in payment of  approximately  $9,170 in accrued  dividends  payable on the
Company's  outstanding  Series B Preferred Stock for the quarter ended March 31,
2004.  The Company  relied upon Section 4(2) of the  Securities  Act of 1933, as
amended,  for an exemption from  registration of these shares and no underwriter
was used in this transaction.

During the period from April 1, 2004 through June 30, 2004,  the Company  issued
an  aggregate   3,000,000   shares  of  common  stock,  in  three  (3)  separate
transactions,  in  exchange  for the  redemption  of  approximately  $75,000  in
outstanding  debenture  balance  and  approximately  $750,000  in cash  from the
exercise of the  affiliated  warrant.  Where the closing  price of the Company's
common stock was in excess of the  respective  price per share on the respective
transaction   date,   the  Company   recognized  a  charge  to  operations   for
"compensation  expense  related  to common  stock  issuances  at less than "fair
value".  The cumulative effect of transactions  where the transaction  price, as
established in the Debenture  Agreement,  was less than the closing price on the
date  of  the  respective  transactions  resulted  in  a  cumulative  charge  to
operations of approximately  $35,000 during this time period.  Additionally,  on
June 29, 2004, the Company issued an additional 1,000,000 shares of common stock
in advance of the exercise of a $25,000 redemption on the outstanding  debenture
payable and a $250,000 cash payment on the exercise of the  affiliated  warrant,
which was received in July 2004.

On May 26, 2004, the Company  issued 300,000 shares of restricted,  unregistered
common stock to two separate  corporations  in payment and full  satisfaction of
all  amounts  due for  fees  and/or  commissions  due in  conjunction  with  the
Company's  convertible  debenture  financing  transaction.  This transaction was
valued at  approximately  $36,000,  which  approximated  the "fair value" of the
underlying  securities given in payment and the related charges for the services


                                                                              18




                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note L - Common Stock Transactions - Continued

provided. The Company relied upon Section 4(2) of the Securities Act of 1933, as
amended,  for an exemption from  registration of these shares and no underwriter
was used in this transaction.

In August 2004,  the Company  issued 29,746 shares of  restricted,  unregistered
common stock in payment of approximately  $9,170 in accrued dividends payable on
the Company's  outstanding  Series B Preferred  Stock for the quarter ended June
30, 2004. The Company relied upon Section 4(2) of the Securities Act of 1933, as
amended,  for an exemption from  registration of these shares and no underwriter
was used in this transaction.


Note M - Rental Commitments

The Company  leases its  corporate  office and  manufacturing  facility from its
controlling stockholder under a long- term operating lease agreement.  The lease
requires a monthly payment of approximately  $5,410,  including applicable sales
taxes.  After the five (5) year and five  month term of this  lease,  should the
parties  desire to renew this lease,  Lessor and Lessee  shall  renegotiate  the
annual rent paid by Lessee.  The Company is  responsible  for all  utilities and
maintenance expenses. The lease expires on December 31, 2009. Total rent expense
under this lease was approximately $67,075 and $54,100,  respectively,  for each
of the years ended December 31, 2003 and 2002.

The  Company's  subsidiary,  IPE,  leases it's  manufacturing  facility  from an
unrelated third-party under a long-term operating lease agreement. This lease is
for a period of five (5) years and requires graduated monthly payments, changing
on the lease anniversary date, ranging from approximately $1,751 to $1,914, plus
the applicable  sales taxes.  The Company is  responsible  for all utilities and
maintenance expenses.  The lease expires on February 28, 2007 and may be renewed
for an additional five (5) year term at a rental rate of  approximately  $1,971,
plus applicable sales taxes for the first renewal year and 3.0% increase on each
succeeding   anniversary   date.   Total  rent  expense  under  this  lease  was
approximately  $20,752 and  $16,622,  respectively,  for each of the years ended
December 31, 2003 and 2002.


                                                                              19





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note M - Rental Commitments - Continued

In May  2004,  the  Company  entered  into a  long-term  lease  agreement  for a
warehouse  facility  adjacent to the Company's  primary office and manufacturing
facility.  This lease is for a period of two (2) years and requires  payments of
approximately  $6,206 per month for the first 12 months and approximately $6,393
for  the  second  12  months,  plus  applicable  sales  taxes.  The  Company  is
responsible  for all utilities and maintenance  expenses.  This lease expires on
May 31, 2006.  Further,  the Company is  responsible  for any  incremental  real
estate  taxes and property  insurance  in excess of the amounts  incurred by the
landlord for the calendar year immediately preceding the execution of the lease.

Future minimum rental payments on the above leases are as follows:

                        Year ended
                        December 31,  Amount  
                        ----------------------
                        2004         $ 138,365
                        2005           166,974
                        2006           117,244
                        2007            72,643
                        2008            68,815
                        2007            68,815
                                     ---------

                        Totals       $ 632,856
                                     =========

Note N - Income Taxes

     The  components of income tax (benefit)  expense for the nine month periods
ended September 30, 2004 and 2003, respectively, are as follows:
                                Nine months     Nine months
                                  ended           ended
                                September 30,   September 30,
                                   2004            2003
                                -------------   -------------
       Federal:
         Current                $     -           $     -
         Deferred                     -                 -
                                -------           -------
                                      -                 -
                                -------           -------
       State:
         Current                      -                 -
         Deferred                     -                 -
                                -------           -------
                                      -                 -
                                -------           -------
         Total                  $     -           $     -
                                =======           =======

                                                                              20





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note N - Income Taxes - Continued

As of December 31, 2003,  the Company has a net operating loss  carryforward  of
approximately  $8,500,000 to offset future  taxable  income.  Subject to current
regulations, components of this carryforward began to expire in 2003. The amount
and  availability  of the net  operating  loss  carryforwards  may be subject to
limitations set forth by the Internal  Revenue Code.  Factors such as the number
of shares ultimately issued within a three year look-back period;  whether there
is a deemed more than 50 percent change in control; the applicable long-term tax
exempt bond rate;  continuity of historical  business;  and subsequent income of
the  Company  all  enter  into  the  annual   computation  of  allowable  annual
utilization of the carryforwards.

The  Company's  income tax expense  (benefit)  for the nine month  periods ended
September 30, 2004 and 2003,  respectively,  differed from the statutory federal
rate of 34 percent as follows:

                                                      Nine months  Nine months
                                                         ended         ended
                                                     September 30, September 30,
                                                         2004          2003
                                                     ---------------------------

Statutory rate applied to loss before income taxes     $ (799,000)  $  (902,000)
Increase (decrease) in income taxes resulting from:
     State income taxes                                         -             -
     Other, including reserve for deferred tax asset      799,000       902,000
                                                       ----------   -----------

       Income tax expense                              $        -   $         -
                                                       ==========   ===========

Temporary  differences,  consisting  primarily of statutory  differences  in the
depreciable  lives for property and equipment,  between the financial  statement
carrying  amounts and tax bases of assets and liabilities  give rise to deferred
tax assets and liabilities as of December 31, 2003 and 2002, respectively:

                                                   December 31,   December 31,
                                                       2003            2002
                                                  ------------------------------

     Deferred tax assets - long-term - net        $   3,000,000   $   2,150,000
     Less valuation allowance                        (3,000,000)     (2,150,000)
                                                  -------------   -------------

       Net Deferred Tax Asset                     $           -   $           -
                                                  =============   =============

During the years ended December 31, 2003 and 2002,  respectively,  the valuation
allowance increased by approximately $656,000 and $629,000.


Note O - Subsequent Events

In October 2004, the Company  issued 53,908 shares of  restricted,  unregistered
common stock in payment of approximately  $9,170 in accrued dividends payable on
the  Company's  outstanding  Series B  Preferred  Stock  for the  quarter  ended
September 30, 2004.  The Company  relied upon Section 4(2) of the Securities Act
of 1933, as amended,  for an exemption from  registration of these shares and no
underwriter was used in this transaction.


                                                                              21





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note O - Subsequent Events - Continued

On October 19,  2004,  the Company  completed  negotiations  and closed an Asset
Purchase  Agreement by and between the Company,  Voluto Ventures LLC (a New York
limited  liability  company  and Voluto  Patent  Holding  Co.,  Inc. (a New York
corporation).  The Company acquired certain  machinery and equipment,  inventory
and the assignment of certain patents and  intellectual  property related to the
manufacture  and  production  of specialty  small-arms  ammunition.  The Company
issued  1,111,111  shares  of  restricted,  unregistered  common  stock  with an
agreed-upon value of $500,000 for this transaction.

The sellers agreed to contractually  restrict their sale of the 1,111,111 shares
of  restricted,  unregistered  common stock to an amount of up to 175,000 shares
per month starting on April 28, 2005.


                (Remainder of this page left blank intentionally)









                                                                              22





Item 2 - Management's Discussion and Analysis or Plan of Operation

(1)  Caution Regarding Forward-Looking Information

Certain  statements  contained  in  this  Quarterly  Report  including,  without
limitation, statements containing the words "believes", "anticipates", "expects"
and  words  of  similar  import,  constitute  forward-looking  statements.  Such
forward-looking  statements  involve known and unknown risks,  uncertainties and
other factors that may cause the actual results,  performance or achievements of
the Company,  or industry  results,  to be materially  different from any future
results,   performance   or   achievements   expressed   or   implied   by  such
forward-looking statements.

Such factors include, among others, the following:  international,  national and
local general economic and market conditions:  demographic  changes; the ability
of the Company to sustain,  manage or  forecast  its growth;  the ability of the
Company to successfully make and integrate acquisitions;  raw material costs and
availability;  new product  development and  introduction;  existing  government
regulations  and  changes  in,  or  the  failure  to  comply  with,   government
regulations;  adverse publicity;  competition; the loss of significant customers
or suppliers;  fluctuations  and  difficulty in forecasting  operating  results;
changes in business strategy or development  plans;  business  disruptions;  the
ability  to attract  and  retain  qualified  personnel;  the  ability to protect
technology; and other factors referenced in this and previous filings.

Given these  uncertainties,  readers of this Quarterly  Report and investors are
cautioned not to place undue reliance on such  forward-looking  statements.  The
Company  disclaims  any  obligation  to update any such  factors or to  publicly
announce the result of any  revisions to any of the  forward-looking  statements
contained herein to reflect future events or developments.

Overview

We  were  incorporated  on  February  1,  2000 in the  State  of  California  as
FirsTelevision.com.  We  subsequently  changed our  corporate  name to FBI Fresh
Burgers International which unsuccessfully marketed a business plan concept of a
national "fast food" restaurant chain.

American Ammunition,  Inc. is a holding company with two operating subsidiaries:
F&F Equipment, Inc. and Industrial Plating Enterprise Co.

F&F Equipment,  Inc. was  incorporated  on October 4, 1983 under the laws of the
State of Florida.  The company was formed to engage  principally in the "import,
export, retail & wholesale of firearms equipment, ammunition & other devices and
for the purpose of transacting any and/or all lawful business." F&F conducts its
business operations under the assumed name of "American Ammunition."

In June  2002,  American  Ammunition,  Inc.  formed a wholly  owned  subsidiary,
Industrial  Plating  Enterprise Co., which started  production on June 14, 2002.
Industrial   Plating  is  a  fully   licensed   and   approved   electrochemical
metallization  facility with  significant  capacity for  processing  our line of
projectiles   as  well  as  other   products   and  services   while   employing
environmentally sound water conservation and proven waste treatment techniques.

During the third  quarter of 2003,  the  Company's  operations  experienced  the
negative  impact of a lower than  anticipated  or budgeted  purchases  by Elliot
Brothers, a significant customer.

However,  during this same time period, the Company has entered into a strategic
alliance with Israel Military  Industries (IMI), an entity owned by the State of
Israel, for the cross-production and sale of various small arms ammunition. This
alliance is anticipated to greatly expand the Company's  catalog of products and
assist in utilizing existing production capacity.

In prior periods, the Company executed a private labeling agreement with Century
International  Arms, Inc.  (Century).  Under this agreement,  the Company was to
produce it's standard catalog of small arms ammunition plus

                                                                              23





one specialty small arms cartridge to Century's  specifications for packaging in
Century's designated  labeling.  This agreement required no modifications to the
Company's  production  line and did not  require the  addition  of  supplemental
personnel  or  equipment.  The  Company  made an  initial  shipment  under  this
agreement to Century during  December 2003. In  early-January  2004, the Company
began to experience  problems with Century regarding  Century's  compliance with
their  performance  criteria under this  agreement.  During the first quarter of
2004, Century defaulted on certain  agreed-upon payment schedules on merchandise
sold during  December  2003.  In repayment of the  outstanding  trade debt,  the
Company accepted  unscheduled product returns as payment of the trade debt. As a
result  of these  issues,  the  Company  recognized  a charge to  operations  of
approximately  $28,000 on it's  business  activity  with  Century.  The returned
merchandise  was repackaged and is resalable by the Company to other  customers.
As of  June  30,  2004,  the  Company  has  cancelled  this  agreement,  and  is
contemplating  litigation against Century for breach of contractual  obligations
under this agreement.

Additionally,  the Company has been awarded  three (3) separate  contracts  from
various  departments  of the U. S.  Government.  Each contract is for an initial
term of one year (commencing between April 24, 2003 and September 30, 2003) with
four (4) successive  individual  one-year extension options,  of which the first
extension period has been exercised. The contracts are summarized as follows:

Contract 1:    U. S. Department of State. Minimum annual volume of approximately
               100,000 rounds of military grade small arms  ammunition.  Maximum
               annual volume of approximately  5,000,000 rounds.  Maximum volume
               may be increased at the discretion of the Contracting Officer and
               respective  utilization  requirements.  The Company has  received
               firm  orders  for  2,265,000  rounds  of  ammunition  under  this
               contract  and  has  approximately   1,265,000  rounds  ready  for
               shipment.  The ammunition  under this contract will be subject to
               the strategic alliance with Israel Military Industries (IWI).

Contract 2:    U. S.  Department  of  Energy.  This  contract  covers  seven (7)
               separate products in the Company's  standard catalog of products.
               The U. S.  Department  of  Energy is  obligated  to  purchase  an
               aggregate of 4,549,000 rounds of ammunition under this contract.

Contract 3:    U. S. Department of Homeland Security.  This contract covers four
               (4) separate  products being introduced to the Company's  catalog
               through  the   strategic   alliance  with  IMI  and  requires  no
               modifications to the Company's production facilities or additions
               to the labor force.  The minimum annual volume is 1,000 rounds of
               each product and a maximum  annual volume of 9,600,000  rounds of
               two  (2)  products  and  36,000,000  of  the  remaining  two  (2)
               products.





                (Remainder of this page left blank intentionally)





                                                                              24





The Company has received purchase orders against these contracts;  however,  due
to delays in receiving the initial purchase orders and the  unpredictability  of
subsequent  reorder cycles, the Company is unable to fully anticipate or predict
the future impact of these contracts.  The Company remains in negotiation and to
prepare  bids on  other  contracts  from  these  and  other  U. S.  Governmental
agencies.

During the first quarter of 2004,  the Company  commenced a direct  solicitation
program for it's "dealer direct" sales program.  As this endeavor has received a
very  positive  initial  response  from the  qualified  retail  resellers of the
Company's  product,  the  announcement  of  this  program  had  a  significantly
detrimental  impact on the Company's  relationship  with wholesale  distributors
and, accordingly, had a significant negative impact on first quarter 2004 sales.
The Company continues to experience increases in customer demand, order size and
reorder quantities in this program by smaller "single store"  owner/operators of
retail outlets selling the Company's products. During November 2004, the Company
qualified  it's  1,000th  dealer  under this  program for direct sales and it is
anticipated  that the overall  Calendar  2004 sales  volume  through the "dealer
direct"  program  may well  equal or  exceed  the  sales  volumes  generated  by
wholesale distributors in prior years.

Results of Operations

Nine months  ended  September  30,  2004  compared  with the nine  months  ended
September 30, 2003.

During the nine and three months ended  September 30, 2004, we  experienced  net
revenues of approximately $1,712,000 and $862,000,  respectively, as compared to
approximately $1,216,000 and $317,000 for the same respective periods of 2003.

During the first quarter of 2004,  the Company  commenced a direct  solicitation
program for it's "dealer direct" sales program.  As this endeavor has received a
very  positive  initial  response  from the  qualified  retail  resellers of the
Company's  product,  the  announcement  of  this  program  had  a  significantly
detrimental  impact on the Company's  relationship  with wholesale  distributors
and, accordingly, had a significant negative impact on first quarter 2004 sales.
The Company  continues to experience  significant  increases in customer demand,
order size and reorder  quantities  in this  program by smaller  "single  store"
owner/operators of retail outlets selling the Company's products.

During  November  2004,  the Company  qualified  it's 1,000th  dealer under this
program for direct sales and it is  anticipated  that the overall  Calendar 2004
sales volume  through the "dealer  direct"  program may well equal or exceed the
sales volumes generated by wholesale distributors in prior years.

We  experienced  costs of goods sold of  approximately  $2,435,000  for the nine
months ended September 30, 2004 as compared to approximately  $2,209,000 for the
nine  months  ended   September   30,  2003.   Included  in  these  amounts  are
approximately $524,000 and $495,000,  respectively,  for depreciation expense on
manufacturing equipment and leasehold improvements on our production facility.

Management is of the opinion that the production  labor force is stable and able
to maintain a constant  standard of quality for future  periods.  We  experience
variable costs in the area of material consumption and direct labor.

These depreciation  levels are anticipated to remain fairly constant as compared
to the first quarter of 2004. Management has placed on order, and placed initial
deposits  on, new  manufacturing  equipment  to automate  the product  packaging
process and to add new quality assurance equipment on the production line. These
commitments  aggregate  approximately  $450,000,  of which the majority has been
expended through September 30, 2004.



                                                                              25





Management,  at this time, does not anticipate any further  significant  capital
equipment acquisitions.

Further,  the addition of the Industrial Plating Enterprise Co. equipment during
2003 allows us to produce certain components which were previously outsourced to
unrelated third parties.

For the nine month periods ended September 30, 2004 and 2003,  respectively,  we
have generated a negative gross profit of approximately $(723,000), or (42.21%),
and approximately $(993,000), or (81.66%).

As  previously  reported,  our  research  during the second  quarter of 2004 has
revealed  that the various  governmental  agencies  which have  issued  purchase
contracts to us either purchased large quantities during the last 60 days of the
Federal   Government's  year  ended  September  30,  2003  or  are  experiencing
transitional  purchasing  problems or issues  surrounding the  reorganization of
various  agencies  into the  Department of Homeland  Security,  with the related
issues of Congressional appropriations for funding the necessary expenditures of
these  reorganized  agencies.  The  actions  of the third  quarter  proved  this
research to be correct and we received  several  purchase  order releases on our
contract with the Department of Homeland  Security.  The timing of Congressional
approval of the related appropriation bills to fund the various executive branch
departments  of the United States of America  continues to impact the timing and
release of purchase orders under our contracts as previously discussed.

We continue to anticipate that with the fulfillment of the government  contracts
discussed  above,  continually  expanding retail consumer demand for our product
line, lower production costs being experienced from internally generated plating
activities and adequate liquidity,  we will be able to generate a positive gross
profit  in  future  periods.  Further,  based  on  production  cost  information
developed  during  the 4th  quarter of 2002 and  further  refined  during  2003,
management  has  developed  a new model for the  pricing of its  products to its
customers.  It is  anticipated  that this model will allow  management to better
manage expense levels, control labor costs and maximize revenue opportunities.

We had minimal  costs  allocated to research  and  development  expenses  during
either of the quarters ended September 30, 2004 and 2003.

Through the nine months ending  September  30, 2004,  we expended  approximately
$368,000 in advertising  and marketing  expenses,  principally in developing and
promoting  our retail  dealer  direct  program.  We  anticipate  to continue our
marketing  efforts  in this area in future  periods;  however,  the  volume  and
frequency of our  expenditures may fluctuate as management  allocates  available
capital to these efforts.

Other general and  administrative  expenses  increased by approximately  $57,000
from  approximately  $789,000  for the nine months ended  September  30, 2003 as
compared to approximately $846,000 for the nine months ended September 30, 2004.
These increases are not  identifiable by one specific area;  however,  relate to
general corporate  expenses,  office and  administrative  wages and salaries and
other related office overhead.

                                                                              26





Included  in our  results of  operations  for the first nine  months of 2004 are
certain non-cash expenditure charges to operations of approximately $356,000 for
compensation  expense  related  to common  stock  issuances  at less than  "fair
value".  The  calculation  of these charges result from our issuing common stock
for either cash or services at valuations  below the closing quoted market price
of our common stock (as discounted,  as applicable) and either the cash received
or the value of the services  provided to us by third parties.  During  Calendar
2003, we experienced a charge of  approximately  $94,000 for the amortization of
the Beneficial  Conversion  Feature Discount on our Preferred Stock. This charge
results  from the  difference  between the closing  quoted  market  price on our
common stock and the  equivalent  converted  price of our Mandatory  Convertible
Preferred Stock which was sold and converted during 2003.

We recognized a net loss of approximately  $(2,350,000) and $(2,662,000) for the
respective three month periods ended September 30, 2004 and 2003,  respectively,
or $(0.03) and $(0.04) per share.

Liquidity And Capital Resources

As  of  September   30,  2004,   December  31,  2003  and  September  30,  2003,
respectively,  we had working capital of approximately $960,000,  $2,000,000 and
$1,348,000.  Our  working  capital  position  continues  to  fluctuate  based on
collections  on our  trade  accounts  receivable  and  receipt  of cash from the
mandatory  exercise  of  our  outstanding  warrant  contractually  tied  to  our
convertible debenture.  Further, we anticipate that we have sufficient inventory
levels to  support  our  retail  dealer  direct  program  and our  existing  and
anticipated U. S. Government contracts.

We have  used cash in  operating  activities  of  approximately  $(727,500)  and
$(1,901,000)   during  the  quarters   ended   September   30,  2004  and  2003,
respectively.

The most  significant  use of cash in  operations  during the nine months  ended
September  30,  2004 was for the  support  of our  operations  where our  costs,
expenses  and  overhead  was in excess of the sales  volume  that we  generated,
including  increased  advertising  and  marketing  expenses to institute our new
retail dealer direct program.

We anticipate that our improved  liquidity  position will continue to improve as
management is of the opinion that the production capacity is in place to support
all existing  orders and accept  existing  inquiries  which have previously been
denied due to the lack of production capacity and liquidity.

During the nine months ended September 30, 2004 and 2003, respectively, we added
approximately $436,000 and $59,000 in new equipment.  Depending on future demand
for our products, we may develop plans to increase our

                                                                              27





production  capacity  by an  additional  50%  to  100%,  as  influenced  by  the
availability  of  manufacturing  equipment on the open market and product  sales
demand.  Management is of the opinion that sufficient demand will be present, as
supported by new product development and increased product marketing efforts, to
justify this expansion. However, we may not be able to obtain additional funding
or, that such funding,  if available,  will be obtained on terms favorable to or
affordable by us.

Convertible Debenture

On October 4, 2002, we signed a Securities Purchase Agreement with La Jolla Cove
Investors,  Inc. (La Jolla) for the sale of a $250,000 8% convertible  debenture
and a warrant  to  purchase  up  30,000,000  shares  of our  common  stock.  The
debenture bears interest at 8% and matures two years from the date of issuance.

In December 2002, the Company and La Jolla, the Debenture and/or Warrant Holder,
amended the above-referenced debenture and warrants as follows:

     The number of common  shares into which the  debenture  may be converted is
     equal to the dollar amount of the debenture being  converted  multiplied by
     eleven, minus the product of the conversion price,  multiplied by ten times
     the  dollar  amount  of  the  debenture  being  converted,  divided  by the
     conversion  price.  The  conversion  price is obtained by  multiplying  the
     average of the five (5) lowest Volume Weighted Average Prices (VWAP) during
     the 20  trading  days  prior  to the  date of  conversion  by the  Discount
     Multiplier of 80%.

     The warrants are exercisable at $1.00 per share for up to 2,500,000 shares.
     The Warrant Holder is obligated to exercise the warrant  concurrently  with
     the  conversion  of the debenture for a number of shares equal to ten times
     the dollar amount of the debenture being converted.

We were obligated to file a Registration  Statement  under the Securities Act of
1933 to register the underlying conversion shares on either Form SB-2 or S-3 and
have said Registration  Statement effective no later than 120 days after October
4, 2002. Our Registration  Statement on Form SB-2 was deemed effective by the U.
S. Securities and Exchange Commission on May 14, 2003 at 1:00 pm EDT.

La Jolla has contractually  committed to convert not less than 5.0% and not more
than 10.0% of the original  face value of the  Debenture  monthly  beginning the
month after the effective date of the Registration  Statement and is required to
concurrently  exercise warrants and purchase shares of common stock equal to ten
(10)  times the  number of shares of common  stock  issued to La Jolla  upon the
respective mandatory conversion of the Debenture.

La Jolla has further contractually agreed to restrict its ability to convert the
Debenture or exercise their warrants and receive shares of our common stock such
that the number of shares held them or their affiliates after such conversion or
exercise does not exceed 4.99% of the then issued and outstanding  shares of our
common stock.

In the event an  election  to convert is made and the  volume  weighted  average
price of our common stock is below $0.30 per share,  we have the right to prepay
any portion of the outstanding Debenture that was elected to be converted,  plus
any accrued and unpaid interest, at 125.0%.

La Jolla could have  demanded  repayment of the  Debenture of 125.0% of the face
amount  outstanding,  plus all accrued and unpaid interest,  in cash at any time
prior to May 14, 2003, the date that underlying Registration Statement under the
Securities  Act of 1933  was  declared  effective  by the U. S.  Securities  and
Exchange Commission, within 3 business days of such demand. If the repayment was
accelerated,  we were  obligated to issue La Jolla 25,000 shares of common stock
and $10,000 cash for each 30 day period,  or portion  thereof,  during which the
face amount, including interest thereon, remains unpaid with the cash payment to
increase to $15,000 for each 30 day period the balance  remains unpaid after the
initial 90 day period.

If La Jolla  does not elect to  accelerate  the  Debenture,  the  Company  shall
immediately  issue and pay La Jolla  25,000  shares of common  stock and $10,000
cash for each 30 day period, or portion thereof, during which the face amount,

                                                                              28





including interest thereon,  remains unpaid with the cash payment to increase to
$15,000 for each 30 day period the balance  remains  unpaid after the initial 90
day period.

Due to the contractually agreed mandatory conversion of this Debenture,  we have
reflected  this  transaction  in our balance sheet as a  "mezzanine"  level debt
obligation on its balance sheet,  between "Total Liabilities" and "Stockholders'
Equity".  Upon  the  respective  mandatory  conversion,   we  will  relieve  the
respective  portion of the  Debenture  and the any related  accrued,  but unpaid
interest,   and  credit  this  amount  to  the  respective  "common  stock"  and
"additional  paid-in capital" accounts in the  stockholder's  equity section for
the par value and  excess  amount  over the par value of the  respective  shares
issued.

As the warrant is  non-detachable  from the Debenture and requires  simultaneous
exercise upon  conversion of the Debenture,  no value was assigned to the issued
warrant.  Upon exercise of the warrant,  the Company will record the issuance of
the  underlying  shares as a new  issuance  of common  stock on the date of each
respective exercise.

Concurrent  with the  execution  of the  Debenture  agreement,  we  executed  an
engagement letter with La Jolla's counsel for legal  representation  with regard
to the  preparation of the  Registration  Statement  under the Securities Act of
1933 on Form SB-2.

On March 13, 2003 and May 6, 2003, La Jolla Cove Investors,  Inc., the holder of
the Company's convertible debenture, advanced the Company an additional $200,000
and $150,000,  respectively,  for working  capital  purposes.  During the second
quarter of 2003, La Jolla elected to allocate the entire  $350,000 in additional
funding to the principal balance of the convertible debenture.

On various  dates  between May 7, 2003 and June 30,  2003,  La Jolla  elected to
convert  an  aggregate  $75,135,  through  six  (6)  separate  transactions,  in
outstanding Debenture principal into restricted, unregistered common stock. This
election   caused  the  Company  to  issue   1,334,777   shares  of  restricted,
unregistered common stock to the Debenture Holder. Additionally, pursuant to the
contract terms,  the Debenture  Holder  concurrently  exercised a portion of the
outstanding  Warrant to purchase  751,350  shares of the  Company's  restricted,
unregistered common stock for gross proceeds of $751,350.

During the period from July 1, 2003  through  September  30,  2003,  the Company
issued  an  aggregate   2,902,129   shares  of  common  stock,  in  15  separate
transactions,  to La Jolla  in  exchange  for the  redemption  of  approximately
$93,500 in outstanding debenture balance and approximately $935,000 in cash from
the exercise of the affiliated warrant. Where the closing price of the Company's
common stock was in excess of the  respective  price per share on the respective
transaction   date,   the  Company   recognized  a  charge  to  operations   for
"compensation  expense  related  to common  stock  issuances  at less than "fair
value".  The cumulative effect of transactions  where the transaction  price, as
established in the Debenture  Agreement,  was less than the closing price on the
date  of  the  respective  transactions  resulted  in  a  cumulative  charge  to
operations of approximately $317,539 during this time period.

In October  2003,  the Company  issued an aggregate  1,659,847  shares of common
stock,  in  3  separate   transactions,   in  exchange  for  the  redemption  of
approximately   $40,000  in  outstanding  debenture  balance  and  approximately
$400,000 in cash from the exercise of the affiliated warrant.  Where the closing
price of the Company's  common stock was in excess of the  respective  price per
share on the respective  transaction  date,  the Company  recognized a charge to
operations for  "compensation  expense related to common stock issuances at less
than "fair value".  The cumulative effect of transactions  where the transaction
price,  as  established  in the Debenture  Agreement,  was less than the closing
price on the date of the respective transactions resulted in a cumulative charge
to operations of approximately $146,189 during this time period.

During the period  from  January 1, 2004  through  March 31,  2004,  the Company
issued  an  aggregate  2,400,000  shares of common  stock,  in two (2)  separate
transactions,  in  exchange  for the  redemption  of  approximately  $50,000  in
outstanding  debenture  balance  and  approximately  $500,000  in cash  from the
exercise of the  affiliated  warrant.  Where the closing  price of the Company's
common stock was in excess of the  respective  price per share on the respective
transaction   date,   the  Company   recognized  a  charge  to  operations   for
"compensation expense related to

                                                                              29





common  stock  issuances at less than "fair  value".  The  cumulative  effect of
transactions  where the  transaction  price,  as  established  in the  Debenture
Agreement,  was less  than  the  closing  price  on the  date of the  respective
transactions  resulted in a cumulative  charge to  operations  of  approximately
$321,000 during this time period.

During the period from April 1, 2004 through June 30, 2004,  the Company  issued
an  aggregate   3,000,000   shares  of  common  stock,  in  three  (3)  separate
transactions,  in  exchange  for the  redemption  of  approximately  $75,000  in
outstanding  debenture  balance  and  approximately  $750,000  in cash  from the
exercise of the  affiliated  warrant.  Where the closing  price of the Company's
common stock was in excess of the  respective  price per share on the respective
transaction   date,   the  Company   recognized  a  charge  to  operations   for
"compensation  expense  related  to common  stock  issuances  at less than "fair
value".  The cumulative effect of transactions  where the transaction  price, as
established in the Debenture  Agreement,  was less than the closing price on the
date  of  the  respective  transactions  resulted  in  a  cumulative  charge  to
operations of approximately  $35,000 during this time period.  Additionally,  on
June 29, 2004, the Company issued an additional 1,000,000 shares of common stock
in advance of the exercise of a $25,000 redemption on the outstanding  debenture
payable and a $250,000 cash payment on the exercise of the  affiliated  warrant,
which was received in July 2004.

Research and Development

Depending  on the  demand  for  new  product  lines  and the  refinement  of our
production  processes  under  our  production  agreement  with  Israel  Military
Industries   (IMI),   an  entity   owned  by  the  State  of  Israel,   for  the
cross-production  and sale of various small arms  ammunition,  we may or may not
incur increased spending on research and development  activities during Calendar
2004.

Further,  additional  ammunition calibers and/or projectiles may be developed by
us depending  upon market  research,  acceptance in the  marketplace of existing
products and  production  capabilities.  At this time,  there are no  definitive
plans for the further introduction of other new products into the marketplace.



Item 3 - Controls and Procedures

As required by Rule 13a-15 under the Exchange  Act,  within the 90 days prior to
the filing date of this report,  the Company  carried out an  evaluation  of the
effectiveness of the design and operation of the Company's  disclosure  controls
and  procedures.  This evaluation was carried out under the supervision and with
the  participation  of  the  Company's  President,  Chief  Executive  and  Chief
Financial Officer.  Based upon that evaluation,  the Company's President,  Chief
Executive and Chief Financial  Officer  concluded that the Company's  disclosure
controls and procedures are effective. There have been no significant changes in
the Company's internal controls or in other factors,  which could  significantly
affect  internal  controls  subsequent  to the date the Company  carried out its
evaluation.

Disclosure  controls and procedures are controls and other  procedures  that are
designed to ensure that information  required to be disclosed in Company reports
filed or submitted under the Exchange Act is recorded, processed, summarized and
reported,  within the time  periods  specified  in the  Securities  and Exchange
Commission's  rules and  forms.  Disclosure  controls  and  procedures  include,
without limitation,  controls and procedures designed to ensure that information
required to be  disclosed  in Company  reports  filed under the  Exchange Act is
accumulated  and  communicated  to  management,  including the  Company's  Chief
Executive  Officer and Chief Financial  Officer as appropriate,  to allow timely
decisions regarding required disclosure.




                                                                              30





                          Part II - Other Information


Item 1 - Legal Proceedings

     None


Item 2 - Recent Sales of Unregistered Securities and Use of Proceeds

     In  August  2004,   the  Company   issued  29,746  shares  of   restricted,
     unregistered  common  stock in payment of  approximately  $9,170 in accrued
     dividends payable on the Company's outstanding Series B Preferred Stock for
     the quarter ended March 31, 2004.  The Company  relied upon Section 4(2) of
     the Securities Act of 1933, as amended,  for an exemption from registration
     of these shares and no underwriter was used in this transaction.

     In  October  2004,   the  Company   issued  53,908  shares  of  restricted,
     unregistered  common  stock in payment of  approximately  $9,170 in accrued
     dividends payable on the Company's outstanding Series B Preferred Stock for
     the quarter ended  September 30, 2004. The Company relied upon Section 4(2)
     of  the  Securities  Act  of  1933,  as  amended,  for  an  exemption  from
     registration   of  these  shares  and  no  underwriter  was  used  in  this
     transaction.

     On October 19, 2004, the Company completed negotiations and closed an Asset
     Purchase  Agreement by and between the Company,  Voluto Ventures LLC (a New
     York limited  liability  company and Voluto Patent Holding Co., Inc. (a New
     York  corporation).  The Company acquired certain  machinery and equipment,
     inventory and the assignment of certain patents and  intellectual  property
     related  to  the  manufacture   and  production  of  specialty   small-arms
     ammunition. The Company issued 1,111,111 shares of restricted, unregistered
     common stock with an agreed-upon value of $500,000 for this transaction.

     The sellers  agreed to  contractually  restrict their sale of the 1,111,111
     shares  of  restricted,  unregistered  common  stock to an  amount of up to
     175,000 shares per month starting on April 28, 2005.


Item 3 - Defaults on Senior Securities

     None


Item 4 - Submission of Matters to a Vote of Security Holders

     None


Item 5 - Other Information

     None



                                                                              31





Item 6 - Exhibits

   Exhibit #      Description
------------   -------------------------------------------------
     31.1 *    Certification  pursuant to Section 302 of  Sarbanes-Oxley  Act of
               2002

     32.1 *    Certification  pursuant to Section 906 of  Sarbanes-Oxley  Act of
               2002.

-----------------------------
* Filed herewith


                                   SIGNATURES

In accordance with the  requirements of the Exchange Act, the registrant  caused
this  report to be  signed on its  behalf  by the  undersigned,  thereunto  duly
authorized.



                           American Ammunition, Inc.



                                  By:     /s/ Andres F. Fernandez
                                  ----------------------------------
                                  Andres F. Fernandez
                                  President, Chief Executive Officer
                                  Chief Financial Officer and Director


Dated: January 11, 2005







                                                                              32